𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A sequential study of serum bacterial DNA in patients with advanced cirrhosis and ascites

✍ Scribed by Rubén Francés; Susana Benlloch; Pedro Zapater; José M. González; Beatriz Lozano; Carlos Muñoz; Sonia Pascual; Juan A. Casellas; Francisco Uceda; José M Palazón; Fernando Carnicer; Miguel Pérez-Mateo; José Such


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
133 KB
Volume
39
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Bacterial translocation is currently considered the main pathogenic mechanism leading to spontaneous bacterial peritonitis in patients with advanced cirrhosis and ascites. However, to the authors' knowledge there is no information regarding the characteristics of this process in humans. The goals of the current study were to pursue partially identified bacterial DNA in blood (what the authors consider molecular evidence of bacterial translocation) through its relative quantification in a 72-hour study period by using real-time polymerase chain reaction (PCR). A consecutive series of 17 patients with advanced cirrhosis and culture-negative, nonneutrocytic ascites were studied. Therapeutic paracentesis was performed at the time of admission, and blood samples were obtained at baseline and every 8 hours in a 3-day period. Bacterial DNA was detected by a PCR-based method, relatively quantified by real-time PCR, and identified by automated nucleotide sequencing. Seven of 17 patients demonstrated the simultaneous presence of bacterial DNA in blood and ascitic fluid at the time of admission. After therapeutic paracentesis was performed, bacterial DNA persisted in the blood for a minimum of 24 hours, and was reported to last as long as 72 hours in some patients. In addition, different patterns of bacterial DNA appearance and clearance from the blood were identified. The nucleotide sequencing process demonstrated that bacteria detected in the first sample were identical to those noted in subsequent detections over time. In conclusion, bacterial translocation is a single-species, dynamic process that appears to develop in a subgroup of patients with advanced cirrhosis.


📜 SIMILAR VOLUMES


Serum and ascitic fluid bacterial DNA: A
✍ Pedro Zapater; Rubén Francés; José M. González-Navajas; Maria A. de la Hoz; Rocí 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

We tested the hypothesis that the presence of bacterial DNA (bactDNA) in ascitic fluid and serum is associated with decreased survival in patients with cirrhosis. In a prospective, multicenter study, we analyzed the clinical evolution of 156 patients with cirrhosis and ascites (first or recurrence)

Bacterial DNA in patients with cirrhosis
✍ Rubén Francés; Pedro Zapater; José M. González-Navajas; Carlos Muñoz; Rocío Caño 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB 👁 2 views

Bacterial infections and severity of associated inflammatory reaction influence prognosis in patients with advanced cirrhosis. We compared the innate immune response to bacterial DNA (bactDNA) translocation with that caused by viable bacteria translocation in patients with spontaneous bacterial peri

The detection of bacterial DNA in blood
✍ Carlos Guarner; José M. González-Navajas; Elisabet Sánchez; Germán Soriando; Rub 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

Bacterial DNA (bactDNA) is present in blood and ascitic fluid (AF) in a third of patients with cirrhosis and ascites, but whether this phenomenon represents episodes of bacterial translocation (BT), strictly considered when culture of mesenteric lymph nodes (MLNs) are positive, remains unknown. This

Cytokine association with bacterial DNA
✍ Ana Gutiérrez; Rubén Francés; Amparo Amorós; Pedro Zapater; Marta Garmendia; Moi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 1 views

## Background: The pathogenesis of inflammatory bowel disease (ibd) involves the interaction between genetic susceptibility, mucosal immunity, and intestinal bacteria. bacterial translocation is a common event in these patients and plays an important role in the perpetuation of chronic intestinal i

Serum α-L-fucosidase activity and early
✍ Maria G. Giardina; Margherita Matarazzo; Roberto Morante; Antonio Lucariello; An 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## BACKGROUND. Serum ␣-L-fucosidase activity is considered a marker of hepatocellular carcinoma. To the authors' knowledge, its clinical usefulness in the early detection of hepatocellular carcinoma in the follow-up of cirrhotic patients has not been reported previously. ## METHODS. The authors

A study of serum peptidases in anicteric
✍ Alexander M. Rutenburg; Esteban P. Pineda; Jerome Fischbein; Julius A. Goldbarg 📂 Article 📅 1964 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB 👁 2 views

T (LAP) and y-glutamyl transpeptidase (GT) are widely distributed in human tissues and fluids. Diagnostically significant elevations of both peptidases in the serum are related almost exclusively to diseases of the liver, bile ducts, or pancreas.lv 2+ 4, 7-10 Both serum LAP and GT are regularly ele